29
Oct

Dr. Robert Den featured in ASCO Post

For men with prostate cancer who have had a prostatectomy and salvage radiation therapy, analyzing their tumor genome provides clues as to whether their cancer will metastasize, thereby enabling clinicians to better personalize treatment options, according to research presented by Robert Den, MD.  ASTRO 2015: Genomic Classifier Appears to Predict Metastasis in Patients With Prostate …

23
Sep

Genomic Analysis for All Cancer Patients

09/17/15 Jefferson expands its cancer treatment to analyze each cancer patient’s tumor with the newest techniques and help doctors identify cutting edge treatment options. (PHILADELPHIA) – Cancer medicine is moving towards understanding what drives each particular patient’s cancer. But not every patient has had access to this level of individualized care. Today, Jefferson announced its …

14
Apr

SKCC Students and Fellows Receive The 2015 AACR Woman In Cancer Research Scholar Awards

The Women in Cancer Research (WICR) Council has selected Ileine Sanchez, BS and Jessica Teh, PhD, MizueTerai, PhD, Arpita Mondal and Kristina Shahriari as recipients of a 2015 WICR Scholar Award. The American Association for Cancer Research were especially pleased to be able to recognize Thomas Jefferson University’s Ileine Sanchez’s, Dr. Jessica Teh’s and Dr. Misue …

14
Apr

Sidney Kimmel Cancer Center Recognized by Commission on Cancer (American College of Surgeons)

75 CANCER PROGRAMS EARN THE OUTSTANDING ACHIEVEMENT AWARD The Commission on Cancer (CoC), a Quality Program of the American College of Surgeons, has presented the 2014 Outstanding Achievement Award (OAA) to 75 CoC-accredited cancer programs in the U.S. This year the Sidney Kimmel Cancer Center has received this achievement. Established in 2004, the OAA recognizes …

14
Apr

DOD Grant Awarded To Drs. Zeigler-Johnson and Amy Leader

Charnita Zeigler-Johnson, PhD, Assistant Professor of Medical Onoclogy and Amy Leader, PhD, Assistant Professor of Medical Oncology have been awarded a DOD Synergistic Award to support a project called, “A neighborhood-based intervention to reduce prostate cancer disparities.” This grant is a 3-year award. Dr. Ziegler Johnson will be serving as s the PI, and Dr. …

14
Apr

SKCC Scientists Show That Cancer Cells Can Use Exosome Transfer To Pass On Agressive Traits

Until recently, researchers thought that cell division was the only way for an aggressive cancer cell to pass its traits along. New evidence is showing that cancers can become more dangerous by exporting aggressive traits to neighboring cells via exosomes. These small packages — bubbles — of membrane released into the extracellular environment hold pieces …

9
Mar

Two Drexel University College of Medicine Professors Receive Grants Through Statewide Refunds for Breast Cancer Research Campaign

The Pennsylvania Breast Cancer Coalition recently awarded two Drexel University College of Medicine researchers (and Sidney Kimmel Cancer Center Members) grants from its statewide Refunds for Breast Cancer Research campaign. Alessandro Fatatis, MD, PhD, professor in the Departments of Pharmacology & Physiology and Pathology & Laboratory Medicine, and Mauricio Reginato, PhD, associate professor in the …

24
Feb

Jefferson Joins Elite Prostate Cancer Clinical Trials Consortium

Only institutions with proven track records of rapidly translating innovative scientific discoveries to improved standards of patient care are granted membership to the Prostate Cancer Clinical Trials Consortium (PCCTC). In November, The Sidney Kimmel Cancer Center at Thomas Jefferson University was appointed membership to the PCCTC, joining 14 other leading academic medical centers in the …

17
Feb

New genomic test can direct appropriate use of radiation therapy following prostate surgery

The identification of the right patients for post-operative radiation therapy and the timing of administering that therapy are not easily answered by clinical risk factors alone. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk may be optimally managed with observation after radical prostatectomy (prostate surgery), while those …

Page 1 of 21